Fundraising Fox
7 Hills Pharma
Houston, US · Delaware corporation · 1 known investors
Find your way into 7 Hills Pharma
Sign up to see every warm intro you have to 7 Hills Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 7 Hills Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
7 Hills Pharma is a clinical-stage drug development company developing first-in-class integrin-targeted agonists intended to improve the effectiveness of cancer immunotherapies and stem cell transplantation. Its lead molecules, Alintegimod and 7HP935, target solid tumors, hematological malignancies, and CD34+ cell-based therapies.
Founders & leadership
RB
Robert BentExecutive
DW
Darren Woodside, PhDSAB Chairman, Co-founder, Collaborator
PV
Peter Vanderslice, PhDCo-founder, Collaborator
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2024
▶$1MraisedJul 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$1MraisedJul 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert BentExecutive Officer
- Joseph BailesDirector
- Stephen A. BentExecutive Officer, Director
- Kala MarathiDirector
- Upendra MarathiExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1M
- Minimum investment
- $250K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does 7 Hills Pharma do?
- 7 Hills Pharma is a clinical-stage drug development company developing first-in-class integrin-targeted agonists intended to improve the effectiveness of cancer immunotherapies and stem cell transplantation. Its lead molecules, Alintegimod and 7HP935, target solid tumors, hematological malignancies, and CD34+ cell-based therapies.
- Who founded 7 Hills Pharma?
- 7 Hills Pharma was founded by Upendra Marathi.
- Who are 7 Hills Pharma's investors?
- 7 Hills Pharma's investors include Cougar Venture Fund.
- How much funding has 7 Hills Pharma raised?
- 7 Hills Pharma has disclosed $1M raised across 1 round.
- Where is 7 Hills Pharma headquartered?
- 7 Hills Pharma is headquartered in Houston, US.